IMTX Immatics N.V.
$6.90▼ -5.61%
Healthcare
Other
Volume 944.2K
Avg Volume (10D) 1.18M
Key Metrics & Fundamentals
Market Cap
$1.05B
P/E Ratio
–
Div Yield
0.00%
52W Range
6.65 - 12.41
% vs 50 MA
-11.68%
% vs 200 MA
-23.87%
RSI-14
43.4
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.38
Free Cash Flow
-$61.33M
Gross Rev
$9.14M
Gross Profit
$9.14M
EBITDA
-$60.92M
COGS
–
Operating Exp
$76.35M
Operating Income
-$67.20M
EBIT
-$67.20M
Pretax Income
-$62.77M
Net Income
-$62.49M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
Bristol Myers Squibb (BMY) Q3 Earnings and Revenues Beat Estimates
Zacks · Oct 29, 2026 7:35 AM ET
Immatics (IMTX) Stock Looks Stretched As PRAME Trial Data Impresses
Simply Wall St. · Oct 28, 2026 9:09 PM ET
Should Updated Trial Results Require Action From Immatics (IMTX) Investors?
Simply Wall St. · Oct 24, 2026 11:20 PM ET
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
GlobeNewswire · Oct 24, 2026 2:30 AM ET
Stifel Initiates Immatics at Buy With $15 Price Target
MT Newswires · Oct 14, 2026 7:27 AM ET
Nanobiotix Appoints Arnd Christ as CFO
MT Newswires · Oct 1, 2026 4:46 PM ET
Immatics and 4 More Stocks See Action From Activist Investors
Barrons.com · Sep 4, 2026 6:59 PM ET
Sector Update: Healthcare Stocks Advance Tuesday Afternoon
MT Newswires · Aug 25, 2026 1:38 PM ET
Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday
MT Newswires · Aug 25, 2026 9:15 AM ET
Sector Update: Healthcare
MT Newswires · Aug 25, 2026 8:58 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IMTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.